M&T Bank Corp Cardiovascular Systems Inc Transaction History

M&T Bank Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$12.74 - $15.12 $52,883 - $62,763	-4,151 Reduced 7.2%	53,503 $728,000
Q4 2022 Feb 13, 2023	BUY	$12.74 - $15.12 $140,751 - $167,045	11,048 Added 23.71%	57,654 $785,000
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $86,281 - $114,575	6,673 Added 16.71%	46,606 $647,000
Q2 2022 Aug 05, 2022	BUY	$13.53 - $23.34 $37,599 - $64,861	2,779 Added 7.48%	39,933 $574,000
Q1 2022 May 09, 2022	BUY	$16.14 - $22.6 $326,350 - $456,972	20,220 Added 119.4%	37,154 $840,000
Q4 2021 Feb 07, 2022	BUY	$18.64 - $36.77 $82,985 - $163,700	4,452 Added 35.67%	16,934 $318,000
Q3 2021 Oct 28, 2021	BUY	$32.83 - $43.0 $20,912 - $27,391	637 Added 5.38%	12,482 $409,000
Q2 2021 Aug 13, 2021	BUY	$34.41 - $44.03 $14,314 - $18,316	416 Added 3.64%	11,845 $505,000
Q1 2021 May 06, 2021	BUY	$37.29 - $47.19 $45,680 - $57,807	1,225 Added 12.01%	11,429 $438,000
Q3 2020 Nov 06, 2020	BUY	$27.86 - $39.35 $63,130 - $89,167	2,266 Added 28.55%	10,204 $401,000
Q2 2020 Jul 29, 2020	BUY	$30.3 - $42.55 $240,521 - $337,761	7,938 New	7,938 $250,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.